Enzyre
1 known investors
Enzyre develops the ENZYSYSTEM, a near-patient blood coagulation testing platform consisting of a blood sampling device, a single-use microfluidic cartridge with reagents, and a reusable processor that measures enzymatic activity in the coagulation cascade and transfers results to the cloud via a mobile app. The system is designed for patients and health care professionals managing coagulation therapy, allowing measured data to be shared with treating physicians remotely.
Investors · 1
Frequently asked questions
- What does Enzyre do?
- Enzyre develops the ENZYSYSTEM, a near-patient blood coagulation testing platform consisting of a blood sampling device, a single-use microfluidic cartridge with reagents, and a reusable processor that measures enzymatic activity in the coagulation cascade and transfers results to the cloud via a mobile app. The system is designed for patients and health care professionals managing coagulation therapy, allowing measured data to be shared with treating physicians remotely.
- Who are Enzyre's investors?
- Enzyre's investors include Novalis Biotech.